Comment on: ‘Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab’-Reference-Cited by-同舟云学术

Comment on: ‘Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab’

Published:2016-02-12 Issue:5 Volume:30 Page:766-766
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Călugăru D,Călugăru M

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

http://www.nature.com/articles/eye20162.pdf

Reference5 articles.

1. Papakostas TD, Lim L, van Zyl T, Miller JB, Modjtahedi BS, Andreoli CM et al. Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab. Eye (Lond) 2015; 30: 79–84.

2. Epstein DL, Algvere PV, van Wendt G, Seregard S, Kvanta A . Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study. Ophthalmology 2012; 119 (12): 2587–2591.

3. Campochiaro PA, Brown DM, Awh CC, Lee SY, Gray S, Saroj N et al. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology 2011; 118 (10): 2041–2049.

4. Călugăru D, Călugăru M . Intravitreal bevacizumab in acute central/hemicentral retinal vein occlusion: three-year results of a prospective clinical study. J Ocul Pharmacol Ther 2015; 31 (2): 78–86.

5. Călugăru D, Călugăru M . Intravitreal aflibercept of macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study. Am J Ophthalmol 2015; 159 (3): 607–608.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion;Graefe's Archive for Clinical and Experimental Ophthalmology;2017-02-21

2. Comparison of Intravitreal Ranibizumab, Aflibercept, and Dexamethasone Implant after Bevacizumab Failure in Macular Edema Secondary to Retinal Vascular Occlusions;Ophthalmologica;2017

3. Reply to ‘Comment on: Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizmab’;Eye;2016-02-12